It was confirmed that GLP-1 RA therapy in addition to standard hypoglycemic drugs significantly reduced inflammation, B type natriuretic peptide values (linked to the improvement of LVEF), hemodynamic effects, arrhythmic burden, and hospitalization for HF worsening in failing heart patients with T2D treated by CRT-d [86]. This evidence concerns the gene GCG and type 2 diabetes mellitus.